Filter by: patients
What is Edronax?

Edronax is an international brand name for the drug reboxetine. It is a Selective Norepinephrine Reuptake Inhibitor (SNRI) antidepressant used for the treatment of depression.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Depressed mood 7 3 Efficacy_major Efficacy_moderate
Cognitive Confusion 1 0
Unrefreshing or poor sleep 1 1 Efficacy_none
Anxious mood 1 1 Efficacy_major
Cognitive impairment 1 0
Pain in arms 1 1 Efficacy_none

See all 7 patients currently taking Edronax

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
1
Moderate
2
Mild
2
None
0

Reported Dosages

  4 mg daily 8 mg daily 10 mg daily 12 mg daily 20 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Edronax (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 2   Side effects too severe: 100%
Did not seem to work 1   Did not seem to work: 50%

See all 2 patients who’ve stopped taking Edronax

Currently Taking Edronax

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Edronax

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Edronax

Always
5 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Edronax

Very
0 0%
Somewhat
1 20%
A little
0 0%
Not at all
4 80%

Cost

Paid out of pocket

Cost of Edronax

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

Report created on May 26, 2012.